Skylands Capital LLC Has $10.84 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Skylands Capital LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 144,390 shares of the company’s stock after selling 9,700 shares during the period. GE HealthCare Technologies makes up 1.5% of Skylands Capital LLC’s investment portfolio, making the stock its 16th largest holding. Skylands Capital LLC’s holdings in GE HealthCare Technologies were worth $10,844,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Allianz SE grew its holdings in GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares during the period. E Fund Management Hong Kong Co. Ltd. grew its stake in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the period. Godsey & Gibb Inc. bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Oakworth Capital Inc. raised its stake in GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after buying an additional 394 shares during the period. Finally, Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies in the second quarter worth approximately $34,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.2%

Shares of GEHC stock opened at $79.22 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company has a market capitalization of $36.10 billion, a price-to-earnings ratio of 17.37, a PEG ratio of 1.74 and a beta of 1.08. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a 50-day simple moving average of $82.71 and a two-hundred day simple moving average of $77.58.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on GEHC shares. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Barclays lifted their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Friday. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Stifel Nicolaus raised their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Finally, Bank of America boosted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Hold” and a consensus price target of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.